Trial of Drugs for Angina of Effort: The Oral Use of Pentaerythritol Tetranitrate,Including a Comparison with Aminophylline and Dihydroxypropyltheophylline
Restricted accessResearch articleFirst published online January, 1958
Trial of Drugs for Angina of Effort: The Oral Use of Pentaerythritol Tetranitrate,Including a Comparison with Aminophylline and Dihydroxypropyltheophylline
BalatreP.MerlenJ. F.GrandjeanL. (1949). Les esters nitrés des polyalcools en thérapeutique cardiovasculaire. Pr. méd., 57, 1067.
2.
BjerlovH. (1943). The use of pentaerythritol tetranitrate in angina pectoris. Svenska Lak. T., 40, 694. Cited by Weitzman (1943).
3.
ColeS. L.KayeH.GriffithG. C. (1957). Assay of anti-anginal agents: I. A curve analysis with multiple control periods. Circulation, 15, 405.
4.
Dailheu-GeoffroyP. (1950). Action comparee de la pentanitrine et les autres vasodilatateurs coronariens dans l'angine de poitrine. L'ouest méd., 3, 37.
5.
FifeR.HowittG.RoyJ. R. (1957). Trial of drugs for angina of effort: The oral use of dihydroxypropyltheophylline and aminophylline. Scot. med. J., 2, 11.
6.
KalmnsonG. M.DrenickE. J.BinderM. J.RosoveL. (1955). Pentaerythrityl tetranitrate in the treatment of angina pectoris: Clinical evaluation. Arch. int. Med., 95, 819.
7.
MarcheJ. (1950). Le traitement des coronarites chroniques par les esters nitrés des polyalcools. Fiches méd., 144, 1.
8.
PerlmanA. (1952). A study of the therapeutic action and toxicity of pentaerythritol tetranitrate. Angiol., 3, 16.
9.
PlotzM. (1952). Pentaerythritol tetranitrate: A new drug for the treatment of coronary insufficiency. N.Y. State J. Med., 52, 2012.
10.
RussekH. I.ZohmanB. L.DorsetV. J. (1955b). Objective evaluation of coronary vasodilator drugs. Amer. J. med. Sci., 229, 46.
11.
RussekH. I.ZohmanB. L.DrummA. E.WeingartenW.DorsetV. J. (1955a). Long-acting coronary vasodilator drugs: Metamine, paveril, nitroglyn and peritrate. Circulation, 12, 169.
12.
TalleyR. W.BeardO. W.DohertyJ. E. (1952). Use of pentaerythritol tetranitrate in treatment of angina pectoris. Amer. Heart J., 44, 866.
13.
Von OettingenW. F.DonahueD. D.LawtonA. H.MonacoA. R.YagodaH.ValaerP. J. (1944). Toxicity and potential dangers of pentaerythritol tetranitrate (PETN). Federal Security Agency, U.S. Publ. Hlth. Ser. Bull., No. 282.
14.
WeitzmaN. D. (1953). Pentaerythritol tetranitrate in the treatment of angina. Brit. med. J., 2, 1409.
15.
WinsorT.HumphreysP. (1952). Influence of pentaerythritol tetranitrate (peritrate) on acute and chronic coronary insufficiency. Angiol., 3, 1.